Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01256554 · ClinicalTrials.gov registry record · Phase 1
Single Session Spine Stereotactic Radiosurgery in Metastatic Epidural Spinal Cord Compression
A Phase 1 study of Metastatic Epidural Spinal Cord Compression, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT01256554: Completed Phase 1 study of Metastatic Epidural Spinal Cord Compression, sponsored by M.D. Anderson Cancer Center.
NCT01256554 is a Phase 1 study of Metastatic Epidural Spinal Cord Compression that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 11 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01256554, a Phase 1 study of Metastatic Epidural Spinal Cord Compression, has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical study is to learn the feasibility of using a single session of radiation, known as spine stereotactic radiosurgery (SSRS), to treat metastatic epidural spinal cord compression.
Primary Outcome
Maximum acceptable Dmax will be that in which there are fewer RM events than TP events prior to 12 months and less than 2 RM events.
Conditions Studied
Interventions
- BEHAVIORAL Questionnaires
- PROCEDURE Stereotactic Radiosurgery (SSRS)
Study Locations (1)
Texas
- University of Texas MD Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2010-12-03 |
| Est. Completion | 2021-10-15 |
| Phase | Phase 1 |
What the finished NCT01256554 record still lists
NCT01256554 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Metastatic Epidural Spinal Cord Compression appearing as the primary indexed condition, and to 2 interventions - of which Questionnaires is the first listed.
NCT01256554 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT01256554 about?
NCT01256554 is a clinical study titled "Single Session Spine Stereotactic Radiosurgery in Metastatic Epidural Spinal Cord Compression". The goal of this clinical study is to learn the feasibility of using a single session of radiation, known as spine stereotactic radiosurgery (SSRS), to treat metastatic epidural spinal cord compression.
What is the current status of trial NCT01256554?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2010-12-03. Estimated completion is 2021-10-15.
What conditions does trial NCT01256554 study?
This clinical trial studies the following conditions: Metastatic Epidural Spinal Cord Compression.
What interventions are being tested in trial NCT01256554?
The interventions under investigation include: Questionnaires (BEHAVIORAL), Stereotactic Radiosurgery (SSRS) (PROCEDURE).
Who is sponsoring clinical trial NCT01256554?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01256554 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Metastatic Epidural Spinal Cord Compression
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01256554's enrollment target sits among peer trials
11 1911th of 2000 higher than 88 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI